Peloton Wealth Strategists Purchases Shares of 995 Intuitive Surgical, Inc. $ISRG

Peloton Wealth Strategists acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the second quarter, Holdings Channel.com reports. The firm acquired 995 shares of the medical equipment provider’s stock, valued at approximately $541,000.

Other large investors also recently modified their holdings of the company. Vanguard Group Inc. increased its stake in Intuitive Surgical by 2.1% in the second quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock valued at $18,115,025,000 after purchasing an additional 670,302 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Intuitive Surgical by 1.4% in the second quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock worth $4,429,590,000 after acquiring an additional 109,904 shares in the last quarter. Norges Bank acquired a new stake in Intuitive Surgical in the second quarter valued at approximately $2,569,260,000. Invesco Ltd. increased its holdings in shares of Intuitive Surgical by 1.7% during the first quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock valued at $2,090,027,000 after acquiring an additional 71,794 shares in the last quarter. Finally, Northern Trust Corp grew its position in Intuitive Surgical by 0.3% in the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock valued at $1,798,465,000 after purchasing an additional 11,988 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, EVP Henry L. Charlton sold 13,731 shares of Intuitive Surgical stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the sale, the executive vice president directly owned 3,056 shares of the company’s stock, valued at approximately $1,772,480. The trade was a 81.80% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Myriam Curet sold 7,562 shares of the stock in a transaction on Tuesday, October 28th. The shares were sold at an average price of $548.43, for a total value of $4,147,227.66. Following the completion of the transaction, the executive vice president directly owned 353 shares in the company, valued at approximately $193,595.79. This represents a 95.54% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 109,274 shares of company stock worth $60,905,626. Company insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on ISRG. Evercore ISI raised their price target on shares of Intuitive Surgical from $450.00 to $540.00 in a research report on Wednesday, October 22nd. Zacks Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 24th. Robert W. Baird set a $655.00 target price on Intuitive Surgical in a research note on Wednesday, October 22nd. Hsbc Global Res upgraded Intuitive Surgical to a “strong-buy” rating in a report on Thursday, October 23rd. Finally, Piper Sandler upped their price objective on Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Two research analysts have rated the stock with a Strong Buy rating, eighteen have issued a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $607.28.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $567.72 on Wednesday. The stock has a market capitalization of $203.51 billion, a P/E ratio of 75.10, a P/E/G ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The stock’s 50-day simple moving average is $510.79 and its 200 day simple moving average is $504.70.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same period in the prior year, the company posted $1.84 EPS. Intuitive Surgical’s revenue was up 22.9% compared to the same quarter last year. Equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.